Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis

Martin Kolb, Bruno Crestani, Toby M. Maher

Source: Eur Respir Rev, 32 (167) 220206; 10.1183/16000617.0206-2022

Journal Issue: March

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Martin Kolb, Bruno Crestani, Toby M. Maher. Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis. Eur Respir Rev, 32 (167) 220206; 10.1183/16000617.0206-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.